Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 9(1): 16850, 2019 11 14.
Artículo en Inglés | MEDLINE | ID: mdl-31727948

RESUMEN

Recombinant protein expression for structural and therapeutic applications requires the use of systems with high expression yields. Escherichia coli is considered the workhorse for this purpose, given its fast growth rate and feasible manipulation. However, bacterial inclusion body formation remains a challenge for further protein purification. We analyzed and optimized the expression conditions for three different proteins: an anti-MICA scFv, MICA, and p19 subunit of IL-23. We used a response surface methodology based on a three-level Box-Behnken design, which included three factors: post-induction temperature, post-induction time and IPTG concentration. Comparing this information with soluble protein data in a principal component analysis revealed that insoluble and soluble proteins have different optimal conditions for post-induction temperature, post-induction time, IPTG concentration and in amino acid sequence features. Finally, we optimized the refolding conditions of the least expressed protein, anti-MICA scFv, using a fast dilution protocol with different additives, obtaining soluble and active scFv for binding assays. These results allowed us to obtain higher yields of proteins expressed in inclusion bodies. Further studies using the system proposed in this study may lead to the identification of optimal environmental factors for a given protein sequence, favoring the acceleration of bioprocess development and structural studies.


Asunto(s)
Clonación Molecular/métodos , Escherichia coli/genética , Antígenos de Histocompatibilidad Clase I/genética , Interleucina-23/genética , Anticuerpos de Cadena Única/genética , Secuencia de Aminoácidos , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Análisis Factorial , Expresión Génica/efectos de los fármacos , Vectores Genéticos/química , Vectores Genéticos/metabolismo , Antígenos de Histocompatibilidad Clase I/química , Antígenos de Histocompatibilidad Clase I/aislamiento & purificación , Humanos , Cuerpos de Inclusión/química , Interleucina-23/química , Interleucina-23/aislamiento & purificación , Isopropil Tiogalactósido/farmacología , Análisis de Componente Principal , Replegamiento Proteico , Subunidades de Proteína/química , Subunidades de Proteína/genética , Subunidades de Proteína/aislamiento & purificación , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Anticuerpos de Cadena Única/química , Anticuerpos de Cadena Única/aislamiento & purificación , Solubilidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...